A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus
Clinical trial NCT07321678 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07321678
- Sponsor
- Ascletis Pharma (China) Co., Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-22
- Primary completion
- 2026-08-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.